VALERIE MARINO: Open Payments
NPI 1700508215 · DEER PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 71 payments from 19 companies in 2025. Trend: 2023 $662 · 2024 $2,386 · 2025 $1,851
Food & beverage: $1,851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $487 |
| Arcutis Biotherapeutics, Inc. | 4 | $228 |
| Novartis Pharmaceuticals Corporation | 11 | $204 |
| Janssen Biotech, Inc. | 10 | $196 |
| Amgen Inc. | 5 | $174 |
| GENZYME CORPORATION | 4 | $84 |
| Biofrontera Inc. | 3 | $61 |
| LEO Pharma Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $48 |
| Galderma Laboratories, L.P. | 2 | $42 |
Products named: SKYRIZI, Zoryve, TREMFYA, COSENTYX, DUPIXENT, RINVOQ, Rhapsido, Otezla.
Industry payments across NY — which companies pay providers there.
